HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Involvement of PGE2 and RANTES in Staphylococcus aureus-induced fever in rats.

Abstract
This study investigated the involvement of prostaglandins and regulated on activation, normal T cell expressed and secreted (RANTES), in fever induced by live Staphylococcus aureus (no. 25923, American Type Culture Collection) injection in rats. S. aureus was injected intraperitoneally at 10(9), 10(10), and 2 × 10(10) colony-forming units (CFU)/cavity, and body temperature (T(b)) was measured by radiotelemetry. The lowest dose of S. aureus induced a modest transient increase in T(b), whereas the two higher doses promoted similar long-lasting and sustained T(b) increases. Thus, the 10(10) CFU/cavity dose was chosen for the remaining experiments. The T(b) increase induced by S. aureus was accompanied by significant decreases in tail skin temperature and increases in PGE(2) levels in the cerebrospinal fluid (CSF) and hypothalamus but not in the venous plasma. Celecoxib (selective cyclooxygenase-2 inhibitor, 2.5 mg/kg po) inhibited the fever and the increases in PGE(2) concentration in the CSF and hypothalamus induced by S. aureus. Dipyrone (120 mg/kg ip) reduced the fever from 2.5 to 4 h and the PGE(2) increase in the CSF but not in the hypothalamus. S. aureus increased RANTES in the peritoneal exudate but not in the CSF or hypothalamus. Met-RANTES (100 μg/kg iv), a chemokine (C-C motif) receptor (CCR)1/CCR5 antagonist, reduced the first 6 h of fever induced by S. aureus. This study suggests that peripheral (local) RANTES and central PGE(2) production are key events in the febrile response to live S. aureus injection. As dipyrone does not reduce PGE(2) synthesis in the hypothalamus, it is plausible that S. aureus induces fever, in part, via a dipyrone-sensitive PGE(2)-independent pathway.
AuthorsJuliano M Martins, Daniela T Longhi-Balbinot, Denis M Soares, Maria José Figueiredo, David do C Malvar, Miriam C C de Melo, Giles A Rae, Glória E P Souza
JournalJournal of applied physiology (Bethesda, Md. : 1985) (J Appl Physiol (1985)) Vol. 113 Issue 9 Pg. 1456-65 (Nov 2012) ISSN: 1522-1601 [Electronic] United States
PMID22936726 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Chemokine CCL5
  • Cyclooxygenase 2 Inhibitors
  • Pyrazoles
  • RANTES, Met-
  • Sulfonamides
  • Dipyrone
  • Celecoxib
  • Dinoprostone
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (pharmacology)
  • Ascitic Fluid (metabolism)
  • Celecoxib
  • Chemokine CCL5 (antagonists & inhibitors, biosynthesis, cerebrospinal fluid, pharmacology)
  • Cyclooxygenase 2 Inhibitors (pharmacology)
  • Dinoprostone (biosynthesis, cerebrospinal fluid)
  • Dipyrone (pharmacology)
  • Fever (drug therapy, etiology, metabolism)
  • Hypothalamus (metabolism)
  • Male
  • Pyrazoles (pharmacology)
  • Rats
  • Rats, Wistar
  • Signal Transduction
  • Staphylococcal Infections (complications, metabolism)
  • Staphylococcus aureus (pathogenicity)
  • Sulfonamides (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: